Abbott Laboratories Statement of Changes in Director/PDMR Shareholding (7027L)
2016年10月5日 - 3:00PM
RNSを含む英国規制内ニュース (英語)
TIDMABT
RNS Number : 7027L
Abbott Laboratories
04 October 2016
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS
BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
AND PERSONS CLOSELY ASSOCIATED WITH THEM
--------------------------------------------------------------------
Details of the person discharging managerial
1. responsibilities/person closely associated
---- --------------------------------------------------------------
a) Name Glenn F. Tilton
---- ------------------------ ------------------------------------
2. Reason for the notification
---- --------------------------------------------------------------
a) Position / status Director
---- ------------------------ ------------------------------------
Initial notification
b) / amendment Initial Notification
---- ------------------------ ------------------------------------
Details of the issuer, emission allowance
market participant, auction platform, auctioneer
3. or auction monitor
---- --------------------------------------------------------------
a) Name Abbott Laboratories
---- ------------------------ ------------------------ ----------
b) LEI HQD377W2YR662HK5JX27
---- ------------------------ ------------------------ ----------
Details of the transaction(s)
Section to be repeated for (i) each type
of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where
4. transactions have been conducted
---- --------------------------------------------------------------
Description
of the financial
instrument,
a) type of instrument Stock Equivalent Units
------------------------ ------------------------------------
Identification
code N/A (No ISIN Code)
---- ------------------------ ------------------------------------
Nature of the Director fees credited to
b) transaction a stock equivalent unit account
---- ------------------------ ------------------------------------
Price(s) Volume(s)
---- ------------------------ ------------------------ ----------
c) USD 42.29 780
------------------------------ ----------------------- ----------
Aggregated information
---------------
- Aggregated
volume
---------------
d) - Price
---- -------------------------------------------------- ----------
Date of the
e) transaction 2016-09-30
---- ------------------------ ------------------------------------
Place of the
f) transaction Outside a trading venue
---- ------------------------ ------------------------------------
Details of the transaction(s)
Section to be repeated for (i) each type
of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where
5 transactions have been conducted
---- --------------------------------------------------------------
Description
of the financial
instrument,
a) type of instrument
-------------------------------------------------- ----------
Identification
code
-------------------------------------------------- ---------------
Nature of the
b) transaction
---- -------------------------------------------------- ----------
Price(s) Volume(s)
------------------------------------------------------ ----------
c)
-------------------------------------------------------- ----------
Aggregated information
---------------
- Aggregated
volume
---------------
d) - Price
---- -------------------------------------------------- ----------
Date of the
e) transaction
---- -------------------------------------------------- ----------
Place of the
f) transaction
---- -------------------------------------------------- ----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAFELESAKFAF
(END) Dow Jones Newswires
October 05, 2016 02:00 ET (06:00 GMT)
Abbott Labs (LSE:ABT)
過去 株価チャート
から 10 2024 まで 11 2024
Abbott Labs (LSE:ABT)
過去 株価チャート
から 11 2023 まで 11 2024
Real-Time news about Abbott Labs (ロンドン証券取引所): 0 recent articles
その他のAbbott Labsニュース記事